85 related articles for article (PubMed ID: 23325283)
21. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
Kim JH; Kim PN; Won HJ; Shin YM
AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
[TBL] [Abstract][Full Text] [Related]
22. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
[TBL] [Abstract][Full Text] [Related]
23. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
[TBL] [Abstract][Full Text] [Related]
24. Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study.
Haochen W; Jian W; Li S; Tianshi L; Xiaoqiang T; Yinghua Z
J Int Med Res; 2018 Jul; 46(7):2650-2657. PubMed ID: 29683022
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
[TBL] [Abstract][Full Text] [Related]
26. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.
El-Kady NM; Esmat G; Mahmoud EH; Darweesh SK; Mahmoud SH; Elagawy WA
Eur J Gastroenterol Hepatol; 2013 May; 25(5):628-33. PubMed ID: 23325283
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
Yi PS; Huang M; Zhang M; Xu L; Xu MQ
Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis.
Chen QW; Ying HF; Gao S; Shen YH; Meng ZQ; Chen H; Chen Z; Teng WJ
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):309-314. PubMed ID: 26428660
[TBL] [Abstract][Full Text] [Related]
29. Combination of Transarterial Chemoembolization (TACE) and Radiofrequency Ablation (RFA) vs. Surgical Resection (SR) on Survival Outcome of Early Hepatocellular Carcinoma: A Meta-Analysis.
Guo W; He X; Li Z; Li Y
Hepatogastroenterology; 2015 May; 62(139):710-4. PubMed ID: 26897959
[TBL] [Abstract][Full Text] [Related]
30. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
31. The clinical efficiency of TACE combined with simultaneous computed tomography-guided radiofrequency ablation for advanced hepatocellular carcinoma.
Yuan P; Wang F; Zhu G; Chen B
Invest New Drugs; 2021 Oct; 39(5):1383-1388. PubMed ID: 33754235
[TBL] [Abstract][Full Text] [Related]
32. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.
Jiang C; Cheng G; Liao M; Huang J
World J Surg Oncol; 2021 Mar; 19(1):81. PubMed ID: 33741001
[TBL] [Abstract][Full Text] [Related]
33. Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma.
Li W; Ni CF
Abdom Radiol (NY); 2019 Jun; 44(6):2268-2275. PubMed ID: 31016345
[TBL] [Abstract][Full Text] [Related]
34. Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art.
Iezzi R; Pompili M; Posa A; Coppola G; Gasbarrini A; Bonomo L
World J Gastroenterol; 2016 Feb; 22(6):1935-42. PubMed ID: 26877601
[TBL] [Abstract][Full Text] [Related]
35. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
Xu Z; Xie H; Zhou L; Chen X; Zheng S
Anal Cell Pathol (Amst); 2019; 2019():8619096. PubMed ID: 31534899
[TBL] [Abstract][Full Text] [Related]
36. Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis.
Lan T; Chang L; Mn R; Wu L; Yuan YF
Medicine (Baltimore); 2016 Apr; 95(15):e3185. PubMed ID: 27082558
[TBL] [Abstract][Full Text] [Related]
37. Medical Treatment for Hepatocellular Carcinoma in Japan.
Kawano Y; Kaneya Y; Aoki Y; Yoshioka M; Matsushita A; Shimizu T; Ueda J; Takata H; Taniai N; Kanda T; Hirakata A; Suzuki H; Yoshida H
J Nippon Med Sch; 2022 May; 89(2):154-160. PubMed ID: 35082203
[TBL] [Abstract][Full Text] [Related]
38. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.
Chen L; Sun J; Yang X
Cancer Lett; 2016 Jan; 370(1):78-84. PubMed ID: 26472630
[TBL] [Abstract][Full Text] [Related]
39. Advances in Diagnostic and Interventional Radiology in Hepatocellular Carcinoma.
Öcal O; Rössler D; Ricke J; Seidensticker M
Dig Dis; 2022; 40(4):458-467. PubMed ID: 34348282
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]